Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1983 1
1984 6
1985 4
1986 5
1987 3
1988 3
1989 1
1990 1
1991 7
1992 6
1993 4
1994 4
1995 5
1996 4
1997 1
1998 2
1999 1
2000 1
2002 2
2003 1
2004 4
2005 1
2006 2
2007 2
2008 5
2009 5
2010 7
2011 6
2012 13
2013 8
2014 7
2015 4
2016 7
2017 2
2018 5
2019 4
2020 3
2021 9
2022 4
2023 3
Text availability
Article attribute
Article type
Publication date

Search Results

146 results
Results by year
Filters applied: . Clear all
Page 1
Antiglutamic acid decarboxylase 65 (GAD65) antibody-associated epilepsy.
Daif A, Lukas RV, Issa NP, Javed A, VanHaerents S, Reder AT, Tao JX, Warnke P, Rose S, Towle VL, Wu S. Daif A, et al. Among authors: reder at. Epilepsy Behav. 2018 Mar;80:331-336. doi: 10.1016/j.yebeh.2018.01.021. Epub 2018 Feb 9. Epilepsy Behav. 2018. PMID: 29433947 Review.
Vitamin D and Multiple Sclerosis: A Comprehensive Review.
Sintzel MB, Rametta M, Reder AT. Sintzel MB, et al. Among authors: reder at. Neurol Ther. 2018 Jun;7(1):59-85. doi: 10.1007/s40120-017-0086-4. Epub 2017 Dec 14. Neurol Ther. 2018. PMID: 29243029 Free PMC article. Review.
Immunomodulatory activity of interferon-beta.
Kasper LH, Reder AT. Kasper LH, et al. Among authors: reder at. Ann Clin Transl Neurol. 2014 Aug;1(8):622-31. doi: 10.1002/acn3.84. Epub 2014 Jul 23. Ann Clin Transl Neurol. 2014. PMID: 25356432 Free PMC article. Review.
Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial.
Calabresi PA, Radue EW, Goodin D, Jeffery D, Rammohan KW, Reder AT, Vollmer T, Agius MA, Kappos L, Stites T, Li B, Cappiello L, von Rosenstiel P, Lublin FD. Calabresi PA, et al. Among authors: reder at. Lancet Neurol. 2014 Jun;13(6):545-56. doi: 10.1016/S1474-4422(14)70049-3. Epub 2014 Mar 28. Lancet Neurol. 2014. PMID: 24685276 Clinical Trial.
Immunoregulation in multiple sclerosis.
Arnason BG, Antel JP, Reder AT. Arnason BG, et al. Among authors: reder at. Ann N Y Acad Sci. 1984;436:133-9. doi: 10.1111/j.1749-6632.1984.tb14785.x. Ann N Y Acad Sci. 1984. PMID: 6241817 Review. No abstract available.
Relapses in multiple sclerosis: Relationship to disability.
Goodin DS, Reder AT, Bermel RA, Cutter GR, Fox RJ, John GR, Lublin FD, Lucchinetti CF, Miller AE, Pelletier D, Racke MK, Trapp BD, Vartanian T, Waubant E. Goodin DS, et al. Among authors: reder at. Mult Scler Relat Disord. 2016 Mar;6:10-20. doi: 10.1016/j.msard.2015.09.002. Epub 2015 Sep 8. Mult Scler Relat Disord. 2016. PMID: 27063617 Review.
146 results